早期乳腺癌的辅助剂德诺苏马布-证据和争议

Laura Moretti1, Laura Richelmi1, Deborah Cosentini1

  • 1Medical Oncology Unit, Department of Medical and Surgical Specialties, Radiological Sciences, and Public Health, University of Brescia. ASST Spedali Civili, Brescia, Italy.

PubMed
概括

辅助剂德诺苏马布与激素治疗对乳腺癌存活率呈现混合结果,但有效预防骨折. 这证实了denosumab的存在.